Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
25.90
-0.06 (-0.23%)
Apr 28, 2026, 3:00 PM CST

SHA:600993 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
984.32,0883,0152,9882,4942,431
Short-Term Investments
----138.81142.01
Trading Asset Securities
1,577506.09142.1463.29674.35106.02
Cash & Short-Term Investments
2,5612,5943,1573,0513,3072,679
Cash Growth
-12.17%-17.85%3.48%-7.72%23.45%15.22%
Accounts Receivable
813.01796.97457.05334.67409.64242.87
Other Receivables
17.5810.7336.5142.5744.9824.94
Receivables
830.59807.7493.56377.24454.62267.81
Inventory
268.6320.87277.63273.48336.2313.92
Other Current Assets
141.9185.0146.5369.48128.18100.85
Total Current Assets
3,8023,8073,9753,7724,2263,361
Property, Plant & Equipment
739.72735.98770.89635.53515.34440.44
Long-Term Investments
136.09140.84148.95152.83151.47176.79
Goodwill
22.9922.9925.2625.2625.2625.26
Other Intangible Assets
110.92114.0693.0990.1137.2836.9
Long-Term Deferred Tax Assets
55.9554.5550.5949.4658.3621.63
Long-Term Deferred Charges
126.25119.97113.482.366.5258.44
Other Long-Term Assets
645.35440.484.622.468.146.27
Total Assets
5,6395,4365,1824,8305,0884,127
Accounts Payable
301.23318.2337.66289.69284.74156.82
Accrued Expenses
47.2563.2869.53105.15118.5141.79
Short-Term Debt
111131.845.888.188
Current Portion of Long-Term Debt
19.0817.81107.799.79--
Current Portion of Leases
--18.4323.1228.1321.14
Current Income Taxes Payable
129.42116.6267.236.2470.9860.42
Current Unearned Revenue
99.9298.1688.6591.86102.7588.18
Other Current Liabilities
143.08142.5783.379.43164.94109.08
Total Current Liabilities
750.97767.64804.36681.07858.14665.44
Long-Term Debt
---100400-
Long-Term Leases
74.3570.3176.293.5912273.21
Long-Term Unearned Revenue
52.1755.4254.5627.8926.9529.03
Long-Term Deferred Tax Liabilities
22.5622.0923.528.6135.372.51
Other Long-Term Liabilities
6.026.0222.0428.4629.5442.53
Total Liabilities
906.06921.49980.66959.621,472812.72
Common Stock
431.05431.05431.05431.05431.05431.05
Additional Paid-In Capital
23.6223.4123.5351.51100.74105.2
Retained Earnings
4,1353,9233,6083,2532,9602,634
Comprehensive Income & Other
2.322.622.962.662.461.28
Total Common Equity
4,5924,3804,0663,7383,4953,171
Minority Interest
141.01135.01135.32131.94121.5142.82
Shareholders' Equity
4,7334,5154,2013,8703,6163,314
Total Liabilities & Equity
5,6395,4365,1824,8305,0884,127
Total Debt
104.4299.13234.22272.29638.23182.35
Net Cash (Debt)
2,4572,4952,9232,7792,6692,496
Net Cash Growth
-9.17%-14.66%5.19%4.14%6.90%13.90%
Net Cash Per Share
5.705.796.816.466.195.80
Filing Date Shares Outstanding
433.85427.22431.05431.05431.05431.05
Total Common Shares Outstanding
433.85427.22431.05431.05431.05431.05
Working Capital
3,0513,0403,1713,0913,3682,696
Book Value Per Share
10.5810.259.438.678.117.36
Tangible Book Value
4,4584,2433,9483,6233,4323,109
Tangible Book Value Per Share
10.289.939.168.407.967.21
Buildings
--289.57290.61293.35290.37
Machinery
--447.54401.77402.1292.67
Construction In Progress
--357.6205.7425.718.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.